Scientists find new check for recurrence risk of gastric cancer
Researchers have developed a technique to identify patients who are more likely to suffer a recurrence of gastric cancer based on the... Read More
Decreased expression of miR-939 contributes to chemoresistance and metastasis of gastric cancer via dysregulation of SLC34A2 and Raf/MEK/ERK pathway
While the development of chemoresistance and metastasis are the leading causes of death for gastric cancer patients, the molecular mechanisms involved remain... Read More
Six Serum-Based miRNAs as Potential Diagnostic Biomarkers for Gastric Cancer
New AACR research shows circulating microRNAs in serum may serve as promising diagnostic biomarkers for patients with gastric cancer.
Ramucirumab Beneficial in Advanced Gastric/GEJ Cancers Regardless of Age
Regardless of age, patients with advanced gastric or gastroesophageal juncture (GEJ) cancer saw a survival benefit when treated with the monoclonal antibody... Read More
Surgical Palliation Enables Solid Food Intake in Advanced Incurable Gastric Cancer
A first of its kind study presented at the 2017 Gastrointestinal Cancers Symposium in San Francisco shows surgical palliation in patients treated... Read More
Nivolumab Improves Survival in Advanced Gastric/GEJ Cancer
At the 2017 Gastrointestinal Cancers Symposium, researchers presented the exciting new study that treatment with nivolumab (Opdivo) reduces the risk of death... Read More
Older Patients with GI Cancers Don’t Always Receive Tx
New research shows older patients with unresected gastric cancer benefit from treatment, but many often do not receive cancer-specific therapy.
New insight into origin of stomach cancer
In a mouse model, researchers found that damage to acid-secreting cells alone doesn’t jump-start the transformation of healthy cells into precancerous cells.... Read More
Second-line Weekly Nab-paclitaxel Noninferior to Paclitaxel for Gastric Cancer
New research out of The Lancet Gastroenterology & Hepatology journal shows that weekly nab-paclitaxel was noninferior to weekly solvent-based paclitaxel as second-line... Read More
Chemotherapy and survival benefit in elderly patients with advanced gastric cancer
A new scoring system developed to help clinicians assess whether elderly patients would benefit from chemo was presented at ASCO’s 2017 Gastrointestinal... Read More